Literature DB >> 17552943

Syndromic craniosynostosis: from history to hydrogen bonds.

Machael L Cunningham1, Marianne L Seto, Chootima Ratisoontorn, Carrie L Heike, Anne V Hing.   

Abstract

The syndromic craniosynostoses, usually involving multiple sutures, are hereditary forms of craniosynostosis associated with extracranial phenotypes such as limb, cardiac, CNS and tracheal malformations. The genetic etiology of syndromic craniosynostosis in humans is only partially understood. Syndromic synostosis has been found to be associated with mutations of the fibroblast growth factor receptor family (FGFR1, -R2, -R3), TWIST1, MSX2, and EFNB1. Apert, Pfeiffer, Crouzon, and Jackson-Weiss syndromes are due to gain-of-function mutations of FGFR2 in either the Ig II-III linker region (Apert) or Ig III domain. Loss of function mutations of TWIST1 and gain-of-function mutations of MSX2 lead to Saethre-Chotzen and Boston-type syndromes, respectively. The mutations in Pfeiffer (FGFR1), Muenke (FGFR3), and Apert syndrome (FGFR2) are caused by the same amino acid substitution in a highly conserved region of the Ig II-III linker region of these proteins, which suggests that these receptor tyrosine kinases have an overlapping function in suture biology. In this review we will discuss the historical descriptions, current phenotypes and molecular causes of the more common forms of syndromic craniosynostosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17552943     DOI: 10.1111/j.1601-6343.2007.00389.x

Source DB:  PubMed          Journal:  Orthod Craniofac Res        ISSN: 1601-6335            Impact factor:   1.826


  54 in total

1.  Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome.

Authors:  Greg Holmes; Claudio Basilico
Journal:  Dev Biol       Date:  2012-06-01       Impact factor: 3.582

2.  Mutation c.943G>T (p.Ala315Ser) in FGFR2 Causing a Mild Phenotype of Crouzon Craniofacial Dysostosis in a Three-Generation Family.

Authors:  Luitgard M Graul-Neumann; Eva Klopocki; Nicolai Adolphs; Martin A Mensah; Wolfram Kress
Journal:  Mol Syndromol       Date:  2017-01-13

Review 3.  Abnormal skull shape.

Authors:  Susan I Blaser
Journal:  Pediatr Radiol       Date:  2008-06

4.  A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors.

Authors:  Nuala Del Piccolo; Sarvenaz Sarabipour; Kalina Hristova
Journal:  J Biol Chem       Date:  2016-12-07       Impact factor: 5.157

5.  Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.

Authors:  Yann Heuzé; Nandini Singh; Claudio Basilico; Ethylin Wang Jabs; Greg Holmes; Joan T Richtsmeier
Journal:  Bone       Date:  2014-03-13       Impact factor: 4.398

Review 6.  Craniosynostosis: molecular pathways and future pharmacologic therapy.

Authors:  Kshemendra Senarath-Yapa; Michael T Chung; Adrian McArdle; Victor W Wong; Natalina Quarto; Michael T Longaker; Derrick C Wan
Journal:  Organogenesis       Date:  2012-10-01       Impact factor: 2.500

7.  A young patient with polyarthralgia and hearing loss: a case report of Muenke syndrome.

Authors:  Manjiri M Didolkar; Emily N Vinson; Ana M Gaca
Journal:  Skeletal Radiol       Date:  2009-05-16       Impact factor: 2.199

Review 8.  Hand in glove: brain and skull in development and dysmorphogenesis.

Authors:  Joan T Richtsmeier; Kevin Flaherty
Journal:  Acta Neuropathol       Date:  2013-03-23       Impact factor: 17.088

9.  A Korean family with the Muenke syndrome.

Authors:  Jae Eun Yu; Dong Ha Park; Soo Han Yoon
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

10.  Quantification of facial skeletal shape variation in fibroblast growth factor receptor-related craniosynostosis syndromes.

Authors:  Yann Heuzé; Neus Martínez-Abadías; Jennifer M Stella; Eric Arnaud; Corinne Collet; Gemma García Fructuoso; Mariana Alamar; Lun-Jou Lo; Simeon A Boyadjiev; Federico Di Rocco; Joan T Richtsmeier
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.